Collection of a mobilized peripheral blood apheresis product from a patient with mucopolysaccharidosis type VII and subsequent CD34+ cell isolation

A. Alex Hofling, Mark S. Sands, Douglas M. Lublin, Gerhard Bauer, Steven Devine

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The effectiveness of bone marrow transplantation for lysosomal storage diseases like mucopolysaccharidosis type VII (MPSVII) suggests that a gene therapy strategy targeting autologous hematopoietic progenitor cells could be successful. Given the severe systemic manifestations of MPSVII including storage disease in the bone and bone marrow, it was unclear whether sufficient numbers of hematopoietic progenitor cells (CD34+) could be mobilized into the peripheral circulation and subsequently purified from these patients. As reported here, G-CSF mobilization and apheresis were successful, providing a product of 4 × 1010 nucleated cells containing 0.3% CD34 + progenitors. CD34 + cells were magnetically separated from the product to a final purity of 85% with a 64% yield. These results indicate that hematopoietic progenitors can safely be gathered from an MPSVII patient in numbers sufficient for the trial of clinical gene therapy applications.

Original languageEnglish (US)
Pages (from-to)151-153
Number of pages3
JournalJournal of Clinical Apheresis
Volume19
Issue number3
DOIs
StatePublished - 2004
Externally publishedYes

Fingerprint

Mucopolysaccharidosis VII
Blood Component Removal
Cell Separation
Hematopoietic Stem Cells
Genetic Therapy
Lysosomal Storage Diseases
Granulocyte Colony-Stimulating Factor
Bone Marrow Transplantation
Bone Marrow
Clinical Trials
Bone and Bones

Keywords

  • β-glucuronidase
  • Gene therapy
  • Lysosomal storage disease
  • Sly syndrome

ASJC Scopus subject areas

  • Hematology

Cite this

Collection of a mobilized peripheral blood apheresis product from a patient with mucopolysaccharidosis type VII and subsequent CD34+ cell isolation. / Hofling, A. Alex; Sands, Mark S.; Lublin, Douglas M.; Bauer, Gerhard; Devine, Steven.

In: Journal of Clinical Apheresis, Vol. 19, No. 3, 2004, p. 151-153.

Research output: Contribution to journalArticle

@article{d5bc7366059149c6943cc8f75c37fba9,
title = "Collection of a mobilized peripheral blood apheresis product from a patient with mucopolysaccharidosis type VII and subsequent CD34+ cell isolation",
abstract = "The effectiveness of bone marrow transplantation for lysosomal storage diseases like mucopolysaccharidosis type VII (MPSVII) suggests that a gene therapy strategy targeting autologous hematopoietic progenitor cells could be successful. Given the severe systemic manifestations of MPSVII including storage disease in the bone and bone marrow, it was unclear whether sufficient numbers of hematopoietic progenitor cells (CD34+) could be mobilized into the peripheral circulation and subsequently purified from these patients. As reported here, G-CSF mobilization and apheresis were successful, providing a product of 4 × 1010 nucleated cells containing 0.3{\%} CD34 + progenitors. CD34 + cells were magnetically separated from the product to a final purity of 85{\%} with a 64{\%} yield. These results indicate that hematopoietic progenitors can safely be gathered from an MPSVII patient in numbers sufficient for the trial of clinical gene therapy applications.",
keywords = "β-glucuronidase, Gene therapy, Lysosomal storage disease, Sly syndrome",
author = "Hofling, {A. Alex} and Sands, {Mark S.} and Lublin, {Douglas M.} and Gerhard Bauer and Steven Devine",
year = "2004",
doi = "10.1002/jca.20018",
language = "English (US)",
volume = "19",
pages = "151--153",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Collection of a mobilized peripheral blood apheresis product from a patient with mucopolysaccharidosis type VII and subsequent CD34+ cell isolation

AU - Hofling, A. Alex

AU - Sands, Mark S.

AU - Lublin, Douglas M.

AU - Bauer, Gerhard

AU - Devine, Steven

PY - 2004

Y1 - 2004

N2 - The effectiveness of bone marrow transplantation for lysosomal storage diseases like mucopolysaccharidosis type VII (MPSVII) suggests that a gene therapy strategy targeting autologous hematopoietic progenitor cells could be successful. Given the severe systemic manifestations of MPSVII including storage disease in the bone and bone marrow, it was unclear whether sufficient numbers of hematopoietic progenitor cells (CD34+) could be mobilized into the peripheral circulation and subsequently purified from these patients. As reported here, G-CSF mobilization and apheresis were successful, providing a product of 4 × 1010 nucleated cells containing 0.3% CD34 + progenitors. CD34 + cells were magnetically separated from the product to a final purity of 85% with a 64% yield. These results indicate that hematopoietic progenitors can safely be gathered from an MPSVII patient in numbers sufficient for the trial of clinical gene therapy applications.

AB - The effectiveness of bone marrow transplantation for lysosomal storage diseases like mucopolysaccharidosis type VII (MPSVII) suggests that a gene therapy strategy targeting autologous hematopoietic progenitor cells could be successful. Given the severe systemic manifestations of MPSVII including storage disease in the bone and bone marrow, it was unclear whether sufficient numbers of hematopoietic progenitor cells (CD34+) could be mobilized into the peripheral circulation and subsequently purified from these patients. As reported here, G-CSF mobilization and apheresis were successful, providing a product of 4 × 1010 nucleated cells containing 0.3% CD34 + progenitors. CD34 + cells were magnetically separated from the product to a final purity of 85% with a 64% yield. These results indicate that hematopoietic progenitors can safely be gathered from an MPSVII patient in numbers sufficient for the trial of clinical gene therapy applications.

KW - β-glucuronidase

KW - Gene therapy

KW - Lysosomal storage disease

KW - Sly syndrome

UR - http://www.scopus.com/inward/record.url?scp=6344219880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=6344219880&partnerID=8YFLogxK

U2 - 10.1002/jca.20018

DO - 10.1002/jca.20018

M3 - Article

C2 - 15493049

AN - SCOPUS:6344219880

VL - 19

SP - 151

EP - 153

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 3

ER -